BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7515667)

  • 1. Guidelines of AgNOR quantitation. Committee on AgNOR Quantitation within the European Society of Pathology.
    Aubele M; Biesterfeld S; Derenzini M; Hufnagl P; Martin H; Ofner D; Ploton D; Rüschoff J
    Zentralbl Pathol; 1994 Mar; 140(1):107-8. PubMed ID: 7515667
    [No Abstract]   [Full Text] [Related]  

  • 2. Technical and methodological aspects of silver staining and measurement of nucleolar organizer region (NOR).
    Trerè D
    Zentralbl Pathol; 1994 Mar; 140(1):11-4. PubMed ID: 7515668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
    Biesterfeld S; Ruoss E; Hufnagl P; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AgNOR proteins as a parameter of the rapidity of cell proliferation.
    Derenzini M; Trerè D
    Zentralbl Pathol; 1994 Mar; 140(1):7-10. PubMed ID: 7515676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
    Derenzini M; Trerè D
    Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AgNOR values in Callender histopathological types of malignant uveal melanomas.
    Mera M
    Rom J Morphol Embryol; 1995; 41(3-4):125-8. PubMed ID: 8772368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential quantification of AgNOR area and number during silver staining by means of an image analysing system.
    Ofner D; Hittmair A; Maier H; Riedmann B; Rumer A; Lucciarini P; Offner F; Mikuz G; Schmid KW
    Zentralbl Pathol; 1994 Mar; 140(1):37-40. PubMed ID: 7515671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Theory and application of silver staining of nucleolus organizer regions (AgNOR)].
    Rüschoff J; Barth P
    Pathologe; 1992 Feb; 13(1):13-9. PubMed ID: 1570277
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histological grading of ductal pancreatic carcinomas. Relationship to silver staining of NOR-associated proteins and to p53 immunoreactivity].
    Reich O; Heinisch G; Justus J
    Zentralbl Pathol; 1994 Mar; 140(1):49-54. PubMed ID: 7515673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of AgNORs in breast cancer].
    Aubele M; Auer G; Jütting U
    Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AgNOR quantification with special reference to staining patterns.
    Rüschoff J; Fauser G; Knüchel R; Hofstädter F
    Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized AgNOR analysis: its usefulness in surgical oncology.
    Ofner D; Schmid KW
    Histochem Cell Biol; 1996 Aug; 106(2):193-6. PubMed ID: 8877379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized AgNOR quantitation.
    Ofner D; Schmid KW
    J Pathol; 1996 Jun; 179(2):218-9. PubMed ID: 8758216
    [No Abstract]   [Full Text] [Related]  

  • 15. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
    Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
    Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of AgNOR analysis in malignant tumors].
    Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):15-22. PubMed ID: 8204559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
    Pedal WP; Warzok RW; Hufnagl P; Roth K
    Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of three different AgNOR counting methods in advanced carcinoma of the prostate.
    Ahiskali R; Alican Y; Ekicioğlu G; Cevik I; Küllü S; Akdaş A
    Prostate; 1995 Feb; 26(2):105-10. PubMed ID: 7531845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology].
    Heinisch G; Barth J
    Zentralbl Pathol; 1994 Mar; 140(1):95-101. PubMed ID: 7515680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of the AgNOR in tumor pathology].
    Pich A; Margaria E; Chiusa L
    Pathologica; 2002 Feb; 94(1):2-9. PubMed ID: 11912874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.